Triple-negative breast cancer (TNBC), a subset of breast cancer, accounts for the majority of breast cancer death due to the lack of specific treatment targets, as TNBC does not express estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-22. Here, ESR1 is linked to breast carcinoma.